Related Experiment Videos
Bacterial toxins as virulence factors: Shiga bacillus dysentery viewed as a toxinosis
The Mount Sinai Journal of Medicine, New York
|January 1, 1977
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A monkey model for enterohemorrhagic Escherichia coli infection.
The Journal of infectious diseases·2001
The National Institutes of Health agenda for international research in micronutrient nutrition and infection interactions.
The Journal of infectious diseases·2000
Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice.
The Journal of infectious diseases·2000
Shiga toxins 1 and 2 translocate differently across polarized intestinal epithelial cells.
Infection and immunity·1999
Shiga toxins stimulate secretion of interleukin-8 from intestinal epithelial cells.
Infection and immunity·1999
Minority undergraduate programs intended to increase participation in biomedical careers.
The Mount Sinai journal of medicine, New York·2012
Future of electronic health records: implications for decision support.
The Mount Sinai journal of medicine, New York·2012
AA amyloidosis: Mount Sinai experience, 1997-2012.
The Mount Sinai journal of medicine, New York·2012
Amyloid neuropathies.
The Mount Sinai journal of medicine, New York·2012
Should your family history of coronary heart disease scare you?
The Mount Sinai journal of medicine, New York·2012
Management of atrial fibrillation: direct factor IIa and Xa inhibitors or "warfarin shotgun"?
The Mount Sinai journal of medicine, New York·2012
Safety and Efficacy of Ceralasertib plus Olaparib for Advanced/Metastatic Triple-Negative Breast Cancer in Three Molecular Strata: The Phase II VIOLETTE Study.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Fruquintinib: Mechanism of Action, Clinical, and Translational Science.
Clinical and translational science·2026
In the wisdom of Odin: modular architecture, receptor trafficking and therapeutic implications.
Expert opinion on therapeutic targets·2026